[
  {
    "ts": null,
    "headline": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
    "summary": "Trump's Pharma Tariff Plan Could Cost Eli Lilly, Pfizer, Amgen $51B a Year",
    "url": "https://finnhub.io/api/news?id=58fa783b95fdbb9abba48ed042be0996576e0fead0d7d94b3f2706f98374e7e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745853637,
      "headline": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
      "id": 134115299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Trump's Pharma Tariff Plan Could Cost Eli Lilly, Pfizer, Amgen $51B a Year",
      "url": "https://finnhub.io/api/news?id=58fa783b95fdbb9abba48ed042be0996576e0fead0d7d94b3f2706f98374e7e8"
    }
  },
  {
    "ts": null,
    "headline": "Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.",
    "summary": "Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.",
    "url": "https://finnhub.io/api/news?id=aee6216db9db89f81b52cb14e46050ab39a4f1c2b5c2e4a626b977ab1e868740",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745848200,
      "headline": "Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.",
      "id": 134149066,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.",
      "url": "https://finnhub.io/api/news?id=aee6216db9db89f81b52cb14e46050ab39a4f1c2b5c2e4a626b977ab1e868740"
    }
  },
  {
    "ts": null,
    "headline": "4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold",
    "summary": "Value investing is essentially about selecting cheap but fundamentally sound stocks. STNE, CSV, ASB & PFE boast low P/CF ratios.",
    "url": "https://finnhub.io/api/news?id=87bb4a3589df5f212f68eb623da13296748cddfdaef0508b012f268116a6216a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745842620,
      "headline": "4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold",
      "id": 134115301,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Value investing is essentially about selecting cheap but fundamentally sound stocks. STNE, CSV, ASB & PFE boast low P/CF ratios.",
      "url": "https://finnhub.io/api/news?id=87bb4a3589df5f212f68eb623da13296748cddfdaef0508b012f268116a6216a"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "summary": "Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Pfizer (NYSE: PFE).",
    "url": "https://finnhub.io/api/news?id=f01ba2d3ec3d103af1c134fd9efc60336bacfb9b7cb29f03b3d41a2a0535ef96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745840820,
      "headline": "3 Dividend Stocks to Buy and Hold for the Next Decade",
      "id": 134115093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Pfizer (NYSE: PFE).",
      "url": "https://finnhub.io/api/news?id=f01ba2d3ec3d103af1c134fd9efc60336bacfb9b7cb29f03b3d41a2a0535ef96"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial",
    "summary": "Results from the trial showed a 32% reduction in the risk of disease-related events.",
    "url": "https://finnhub.io/api/news?id=bf402e6d76da1c478d2553d6797022c4284021510fa7db8e0cb809c14516c9fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745837044,
      "headline": "Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial",
      "id": 134115303,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Results from the trial showed a 32% reduction in the risk of disease-related events.",
      "url": "https://finnhub.io/api/news?id=bf402e6d76da1c478d2553d6797022c4284021510fa7db8e0cb809c14516c9fd"
    }
  },
  {
    "ts": null,
    "headline": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
    "summary": "The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House.  You can still find attractive stocks despite all of the turbulence.  Here are my five top stocks to buy right now in this highly volatile market.",
    "url": "https://finnhub.io/api/news?id=9c91bc8ed1f617458ab141d77afce597910a92f4723465995672684a4a7e4cea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745830080,
      "headline": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
      "id": 134115304,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House.  You can still find attractive stocks despite all of the turbulence.  Here are my five top stocks to buy right now in this highly volatile market.",
      "url": "https://finnhub.io/api/news?id=9c91bc8ed1f617458ab141d77afce597910a92f4723465995672684a4a7e4cea"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=31da2af189e530b926aa90177add328bfc342db16d48cef11317acf909e0e91d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745824059,
      "headline": "Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings",
      "id": 134115305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=31da2af189e530b926aa90177add328bfc342db16d48cef11317acf909e0e91d"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: positive trial for sasanlimab in bladder cancer",
    "summary": "Pfizer announced that a Phase 3 trial demonstrated that sasanlimab, in combination with BCG induction and maintenance, has significantly improved event-free survival in patients with high-risk...",
    "url": "https://finnhub.io/api/news?id=25200af79c162b4c972d01f33e71a85f201973d1f02febd62eb464daeb283b6e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745814982,
      "headline": "Pfizer: positive trial for sasanlimab in bladder cancer",
      "id": 134112125,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer announced that a Phase 3 trial demonstrated that sasanlimab, in combination with BCG induction and maintenance, has significantly improved event-free survival in patients with high-risk...",
      "url": "https://finnhub.io/api/news?id=25200af79c162b4c972d01f33e71a85f201973d1f02febd62eb464daeb283b6e"
    }
  }
]